
OLD Category: immuno-oncology
April 15, 2019 / Cancer Immunol Res.
The tumor immune microenvironment drives a prognostic relevance that correlates with bladder cancer subtypes
April 12, 2019 / Surg Oncol Clin N Am.
Future Research Goals in Immunotherapy
April 10, 2019 / J Immunother Cancer.
Immune profiling of pre- and post-treatment breast cancer tissues from the SWOG S0800 neoadjuvant trial
April 8, 2019 / Nat Neurosci.
Control of tumor-associated macrophages and T cells in glioblastoma via AHR and CD39
April 8, 2019 / Cancer Immunol Immunother.
Immune-phenotyping of pleomorphic dermal sarcomas suggests this entity as a potential candidate for immunotherapy
April 7, 2019 / Oncoimmunology
Oncolytic virus immunotherapy induces immunogenic cell death and overcomes STING deficiency in melanoma
April 1, 2019 / Cancer Biother Radiopharm.
An IL-15 Superagonist, ALT-803, Enhances Antibody-Dependent Cell-Mediated Cytotoxicity Elicited by the Monoclonal Antibody NEO-201 Against Human Carcinoma Cells
March 26, 2019 / PLoS One.